JP4991543B2 - ジアリールシクロアルキル誘導体の製造方法 - Google Patents

ジアリールシクロアルキル誘導体の製造方法 Download PDF

Info

Publication number
JP4991543B2
JP4991543B2 JP2007528733A JP2007528733A JP4991543B2 JP 4991543 B2 JP4991543 B2 JP 4991543B2 JP 2007528733 A JP2007528733 A JP 2007528733A JP 2007528733 A JP2007528733 A JP 2007528733A JP 4991543 B2 JP4991543 B2 JP 4991543B2
Authority
JP
Japan
Prior art keywords
compound
cis
formula
alkyl
ylmethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007528733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510761A (ja
JP2008510761A5 (cg-RX-API-DMAC7.html
Inventor
クリストフ・サラナ
フランク・ツォハー
アンドレーアス・ブルガルト
ベルント・ユンカー
ロルフ・ヘールライン
トーマス・シュテュデマン
クラウス−ユルゲン・マイアー
ヨッヘン・ハハテル
ヴォルフガング・ホラ
クリストフ・タッペルツホーフェン
ベルント・クリッツァー
ステファン・ムティ
Original Assignee
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング filed Critical サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Publication of JP2008510761A publication Critical patent/JP2008510761A/ja
Publication of JP2008510761A5 publication Critical patent/JP2008510761A5/ja
Application granted granted Critical
Publication of JP4991543B2 publication Critical patent/JP4991543B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2007528733A 2004-08-23 2005-08-23 ジアリールシクロアルキル誘導体の製造方法 Expired - Fee Related JP4991543B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004040736.3 2004-08-23
DE102004040736A DE102004040736B4 (de) 2004-08-23 2004-08-23 Verfahren zur Herstellung von Diarylcycloalkylderivaten
PCT/EP2005/009095 WO2006021420A2 (de) 2004-08-23 2005-08-23 Verfahren zur herstellung von diarylcycloalkylderivaten

Publications (3)

Publication Number Publication Date
JP2008510761A JP2008510761A (ja) 2008-04-10
JP2008510761A5 JP2008510761A5 (cg-RX-API-DMAC7.html) 2008-10-09
JP4991543B2 true JP4991543B2 (ja) 2012-08-01

Family

ID=35745474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007528733A Expired - Fee Related JP4991543B2 (ja) 2004-08-23 2005-08-23 ジアリールシクロアルキル誘導体の製造方法

Country Status (27)

Country Link
US (2) US7803950B2 (cg-RX-API-DMAC7.html)
EP (1) EP1786913B1 (cg-RX-API-DMAC7.html)
JP (1) JP4991543B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070048741A (cg-RX-API-DMAC7.html)
CN (1) CN101014714B (cg-RX-API-DMAC7.html)
AR (1) AR053760A1 (cg-RX-API-DMAC7.html)
AT (1) ATE520785T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005276642B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514000A (cg-RX-API-DMAC7.html)
CA (1) CA2578342A1 (cg-RX-API-DMAC7.html)
CY (1) CY1112080T1 (cg-RX-API-DMAC7.html)
DE (1) DE102004040736B4 (cg-RX-API-DMAC7.html)
DK (1) DK1786913T3 (cg-RX-API-DMAC7.html)
ES (1) ES2371762T3 (cg-RX-API-DMAC7.html)
IL (1) IL181339A0 (cg-RX-API-DMAC7.html)
MA (1) MA28796B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007001872A (cg-RX-API-DMAC7.html)
NO (1) NO20071316L (cg-RX-API-DMAC7.html)
NZ (1) NZ553602A (cg-RX-API-DMAC7.html)
PL (1) PL1786913T3 (cg-RX-API-DMAC7.html)
PT (1) PT1786913E (cg-RX-API-DMAC7.html)
RU (1) RU2414459C2 (cg-RX-API-DMAC7.html)
SI (1) SI1786913T1 (cg-RX-API-DMAC7.html)
TW (1) TW200621734A (cg-RX-API-DMAC7.html)
UY (1) UY29082A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006021420A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700635B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101381302B (zh) * 2007-09-07 2013-04-03 上海睿智化学研究有限公司 2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
CA2710538A1 (en) * 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728899A (en) * 1995-03-27 1998-03-17 Hoechst Marion Roussel Inc. Preparation of cis-4-O-protected-2-cyclopentenol derivatives
BR0212158A (pt) * 2001-08-31 2004-07-13 Aventis Pharma Gmbh Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
WO2003072100A1 (en) * 2002-02-25 2003-09-04 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7094795B2 (en) * 2003-02-27 2006-08-22 Sanofi-Aventis Deutschland Gmbh Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
DE10308350B4 (de) * 2003-02-27 2006-06-01 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
WO2005040394A1 (fr) * 2003-10-22 2005-05-06 Rhodia Chimie Procede de fabrication de compose comprenant un groupement hydroxyle libre et un groupement hydroxyle protégé par une fonction ester par reaction enzymatique
DE102004038403B4 (de) * 2004-08-07 2006-08-31 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten

Also Published As

Publication number Publication date
SI1786913T1 (sl) 2011-12-30
WO2006021420A2 (de) 2006-03-02
KR20070048741A (ko) 2007-05-09
US20080051583A1 (en) 2008-02-28
JP2008510761A (ja) 2008-04-10
AR053760A1 (es) 2007-05-23
ATE520785T1 (de) 2011-09-15
DE102004040736A1 (de) 2006-03-02
UY29082A1 (es) 2006-03-31
DE102004040736B4 (de) 2007-01-11
EP1786913B1 (de) 2011-08-17
AU2005276642A1 (en) 2006-03-02
MX2007001872A (es) 2007-04-24
EP1786913A2 (de) 2007-05-23
DK1786913T3 (da) 2011-11-28
BRPI0514000A (pt) 2008-05-20
WO2006021420A3 (de) 2006-12-21
NO20071316L (no) 2007-05-22
US7803950B2 (en) 2010-09-28
RU2414459C2 (ru) 2011-03-20
CA2578342A1 (en) 2006-03-02
ZA200700635B (en) 2010-01-27
NZ553602A (en) 2010-04-30
ES2371762T3 (es) 2012-01-09
MA28796B1 (fr) 2007-08-01
PT1786913E (pt) 2011-10-31
PL1786913T3 (pl) 2012-01-31
RU2007110644A (ru) 2008-09-27
IL181339A0 (en) 2007-07-04
CN101014714B (zh) 2012-05-23
TW200621734A (en) 2006-07-01
WO2006021420B1 (de) 2007-02-08
AU2005276642B2 (en) 2011-12-22
US20070197614A1 (en) 2007-08-23
CY1112080T1 (el) 2015-11-04
CN101014714A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
CZ329792A3 (en) Process for preparing optically pure (+)-r-2-phenoxypropionic acids esters
EP2537825A1 (en) Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
US20070197788A1 (en) Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases
US7803950B2 (en) Method for the production of diarylcycloalkyl derivatives
JP2006519001A (ja) シス−1,3−シクロヘキサンジオール誘導体のエナンチオマー形の製造法
KR20070076549A (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
HK1105999A (en) Method for the production of diarylcycloalkyl derivatives
US7094908B2 (en) Reduction of carbonyl compounds using the carbonyl reductase of Kluyveromyces marxianus
JP3704731B2 (ja) 光学活性3−ヒドロキシヘキサン酸類の製造方法
EP1086942B1 (en) Optically active alcohols and processes for the preparation thereof
US5047346A (en) Optically active 3-(2-trifluoro-1-hydroxyethyl)propenyl benzyl ether, derivatives thereof, method for preparing the same and use thereof for liquid crystal compound
JP4510809B2 (ja) 光学的に活性なフェニルグリシデートを調製するための、立体選択的な化学酵素的方法
JP2974181B2 (ja) シクロブタノールの新規な製造法
HK40068366A (en) Process for producing acyloxymethyl esters of (4s)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acid
HK1104579A (en) Method for producing the enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases
JPWO2004092113A1 (ja) 光学活性2−アリルカルボン酸誘導体およびその製造法
JP2000256236A (ja) 光学活性アルコール化合物の製造方法
JP2002114749A (ja) 光学活性2−ヒドロキシ−3−フェニルプロピオニトリル誘導体の製造法
JP2001278871A (ja) オキサゾリジン化合物およびその製造方法
JPH11279154A (ja) α、α’−ジアミノアルコール誘導体の製造法
JPH05227986A (ja) 光学活性〔2,2〕パラシクロファン化合物の製造方法
JP2007314426A (ja) 2−メチルグリシジルエステルの新規製法
HK1088889B (en) Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives
JP2007297301A (ja) 3,4−ジヒドロキシ−3−メチルブチロニトリルの製造法
WO2004106534B1 (en) The enzymatic method of making 1,2-diol derivatives and their esters with succine anhydride

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080821

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111026

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120410

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120507

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150511

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees